Anti-FA78A/ FAM78A/ C9orf59 functional antibody

Anti-FA78A/ FAM78A/ C9orf59 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FAM78A/FAM78A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1487-Ab-1/ GM-Tg-hg-SE1487-Ab-2Anti-Human FAM78A monoclonal antibodyHuman
GM-Tg-rg-SE1487-Ab-1/ GM-Tg-rg-SE1487-Ab-2Anti-Rat FAM78A monoclonal antibodyRat
GM-Tg-mg-SE1487-Ab-1/ GM-Tg-mg-SE1487-Ab-2Anti-Mouse FAM78A monoclonal antibodyMouse
GM-Tg-cynog-SE1487-Ab-1/ GM-Tg-cynog-SE1487-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM78A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1487-Ab-1/ GM-Tg-felg-SE1487-Ab-2Anti-Feline FAM78A monoclonal antibodyFeline
GM-Tg-cang-SE1487-Ab-1/ GM-Tg-cang-SE1487-Ab-2Anti-Canine FAM78A monoclonal antibodyCanine
GM-Tg-bovg-SE1487-Ab-1/ GM-Tg-bovg-SE1487-Ab-2Anti-Bovine FAM78A monoclonal antibodyBovine
GM-Tg-equg-SE1487-Ab-1/ GM-Tg-equg-SE1487-Ab-2Anti-Equine FAM78A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1487-Ab-1/ GM-Tg-hg-SE1487-Ab-2; GM-Tg-rg-SE1487-Ab-1/ GM-Tg-rg-SE1487-Ab-2;
GM-Tg-mg-SE1487-Ab-1/ GM-Tg-mg-SE1487-Ab-2; GM-Tg-cynog-SE1487-Ab-1/ GM-Tg-cynog-SE1487-Ab-2;
GM-Tg-felg-SE1487-Ab-1/ GM-Tg-felg-SE1487-Ab-2; GM-Tg-cang-SE1487-Ab-1/ GM-Tg-cang-SE1487-Ab-2;
GM-Tg-bovg-SE1487-Ab-1/ GM-Tg-bovg-SE1487-Ab-2; GM-Tg-equg-SE1487-Ab-1/ GM-Tg-equg-SE1487-Ab-2
Products NameAnti-FAM78A monoclonal antibody
Formatmab
Target NameFAM78A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FAM78A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1487-Ag-1Recombinant multi-species FA78A/ FAM78A/ C9orf59 protein


    Target information

    Target IDGM-SE1487
    Target NameFAM78A
    Gene ID286336,241303,499776,715560,480692,101087884,506709,100066755
    Gene Symbol and SynonymsA130092J06Rik,C9orf59,FAM78A,RGD1566351
    Uniprot AccessionQ5JUQ0
    Uniprot Entry NameFA78A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000126882
    Target ClassificationN/A

    The target: FAM78A, gene name: FAM78A, also named as C9orf59. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.